{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:45:05Z","timestamp":1790264705815,"version":"4.1.0"},"reference-count":66,"publisher":"American Society for Clinical Investigation","issue":"8","funder":[{"name":"Novartis","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["K12CA076931,T32CA009615,K08CA166039,R01CA174951,K24CA198315"],"award-info":[{"award-number":["K12CA076931,T32CA009615,K08CA166039,R01CA174951,K24CA198315"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000982","name":"Conquer Cancer Foundation","doi-asserted-by":"crossref","award":["Career Development Award (to Dr. Maus)"],"award-info":[{"award-number":["Career Development Award (to Dr. Maus)"]}],"id":[{"id":"10.13039\/100000982","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000982","name":"Conquer Cancer Foundation","doi-asserted-by":"crossref","award":["Career Development Award (to Dr. Garfall)"],"award-info":[{"award-number":["Career Development Award (to Dr. Garfall)"]}],"id":[{"id":"10.13039\/100000982","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,19]]},"abstract":"<jats:p>\n                    <jats:bold>BACKGROUND.<\/jats:bold>\n                    Multiple myeloma is usually fatal due to serial relapses that become progressively refractory to therapy. CD19 is typically absent on the dominant multiple myeloma cell population but may be present on minor subsets with unique myeloma-propagating properties. To target myeloma-propagating cells, we clinically evaluated autologous T cells transduced with a chimeric antigen receptor (CAR) against CD19 (CTL019).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>METHODS.<\/jats:bold>\n                    Subjects received CTL019 following salvage high-dose melphalan and autologous stem cell transplantation (ASCT). All subjects had relapsed\/refractory multiple myeloma and had previously undergone ASCT with less than 1 year progression-free survival (PFS).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS.<\/jats:bold>\n                    ASCT + CTL019 was safe and feasible, with most toxicity attributable to ASCT and no severe cytokine release syndrome. Two of 10 subjects exhibited significantly longer PFS after ASCT + CTL019 compared with prior ASCT (479 vs. 181 days; 249 vs. 127 days). Correlates of favorable clinical outcome included peak CTL019 frequency in bone marrow and emergence of humoral and cellular immune responses against the stem-cell antigen Sox2. Ex vivo treatment of primary myeloma samples with a combination of CTL019 and CAR T cells against the plasma cell antigen BCMA reliably inhibited myeloma colony formation in vitro, whereas treatment with either CAR alone inhibited colony formation inconsistently.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSION.<\/jats:bold>\n                    CTL019 may improve duration of response to standard multiple myeloma therapies by targeting and precipitating secondary immune responses against myeloma-propagating cells.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>TRIAL REGISTRATION.<\/jats:bold>\n                    Clinicaltrials.gov identifier NCT02135406.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>FUNDING.<\/jats:bold>\n                    Novartis, NIH, Conquer Cancer Foundation.\n                  <\/jats:p>","DOI":"10.1172\/jci.insight.120505","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T11:02:49Z","timestamp":1524049369000},"source":"Crossref","is-referenced-by-count":146,"title":["Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma"],"prefix":"10.1172","volume":"3","author":[{"given":"Alfred L.","family":"Garfall","sequence":"first","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Stadtmauer","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ting","family":"Hwang","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2882-1962","authenticated-orcid":true,"given":"Simon F.","family":"Lacey","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Joseph","family":"Melenhorst","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Krevvata","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Carroll","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Matsui","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuju","family":"Wang","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav V.","family":"Dhodapkar","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine, New Haven, Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Dhodapkar","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine, New Haven, Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6497-5240","authenticated-orcid":true,"given":"Rituparna","family":"Das","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine, New Haven, Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan T.","family":"Vogl","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan M.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Mangan","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Ayers","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene","family":"Nunez-Cruz","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Kulikovskaya","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M.","family":"Davis","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lamontagne","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Dengel","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseem D.S.","family":"Kerr","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina M.","family":"Young","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald L.","family":"Siegel","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Levine","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Milone","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela V.","family":"Maus","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0241-3557","authenticated-orcid":true,"given":"Carl H.","family":"June","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2018,4,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.11.007"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12563"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2017.09.020"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.12.007"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-436220"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.72653.x"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-510453"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.211"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb07678.x"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.3.1023"},{"issue":"3","key":"B11","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood.V83.3.724.724","article-title":"Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma","volume":"83","author":"Pilarski","year":"1994","journal-title":"Blood"},{"key":"B12","first-page":"17","article-title":"The blood B-cells and bone marrow plasma cells in patients with multiple myeloma share identical IgH rearrangements","volume":"194","author":"Bergsagel","year":"1995","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"B13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/blood.V85.2.436.436","article-title":"In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain","volume":"85","author":"Bergsagel","year":"1995","journal-title":"Blood"},{"issue":"5","key":"B14","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1182\/blood.V87.5.1972.1972","article-title":"Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells","volume":"87","author":"Chen","year":"1996","journal-title":"Blood"},{"issue":"8","key":"B15","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood.V92.8.2844","article-title":"A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction","volume":"92","author":"Szczepek","year":"1998","journal-title":"Blood"},{"issue":"2","key":"B16","first-page":"585","article-title":"In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease","volume":"6","author":"Pilarski","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"3","key":"B17","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood.V95.3.1056.003k26_1056_1065","article-title":"Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice","volume":"95","author":"Pilarski","year":"2000","journal-title":"Blood"},{"issue":"13","key":"B18","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1182\/blood.V96.13.4357","article-title":"Frequency and kinetics of polyclonal and clonal B cells in the peripheral blood of patients being treated for multiple myeloma","volume":"96","author":"Rasmussen","year":"2000","journal-title":"Blood"},{"issue":"12","key":"B19","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1182\/blood.V95.12.4020","article-title":"Levels of circulating CD19+ cells in patients with multiple myeloma","volume":"95","author":"Rasmussen","year":"2000","journal-title":"Blood"},{"key":"B20","first-page":"275","article-title":"Multiple myeloma includes phenotypically defined subsets of clonotypic CD20+ B cells that persist during treatment with rituximab","volume":"2","author":"Pilarski","year":"2008","journal-title":"Clin Med Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.024778"},{"issue":"10","key":"B22","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1182\/blood.V94.10.3576.422k01_3576_3582","article-title":"The proliferative potential of myeloma plasma cells manifest in the SCID-hu host","volume":"94","author":"Yaccoby","year":"1999","journal-title":"Blood"},{"issue":"10","key":"B23","first-page":"3198","article-title":"Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors","volume":"8","author":"Pilarski","year":"2002","journal-title":"Clin Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(01)00788-3"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-09-3064"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0611682104"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0531"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.80"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.140"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-299396"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704317"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nm1310"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-296822"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3910"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504542"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.10.011"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0418"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404284"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.01.004"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30189-4"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407222"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aac5415"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.08.020"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-396853"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-08-524025"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20062387"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-632919"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-195008"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-711903"},{"issue":"22","key":"B50","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.1147.1147","article-title":"B-cell maturation antigen (BCMA)-specific chimeric antigen receptor T cells (CART-BCMA) for multiple myeloma (MM): Initial safety and efficacy from a phase I study","volume":"128","author":"Cohen","year":"2016","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"crossref","unstructured":"Berdeja JG, et al. Durable clinical responses in heavily pretreated patients with relapsed\/refractory multiple myeloma: Updated results from a multicenter study of bb2121 anti-Bcma CAR T cell therapy. Blood. 2017;130(Suppl 1):740 LP-740. http:\/\/www.bloodjournal.org\/content\/130\/Suppl_1\/740.abstract","DOI":"10.1182\/blood.V130.Suppl_1.740.740"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.08.009"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404085"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704713"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705982"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.201"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.03.023"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0170"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/nature13305"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2013.02.013"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.02.025"},{"key":"B62","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/302145","article-title":"Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation","volume":"2011","author":"Kobold","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.12.030"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-711903"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4409"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-3096"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/120505\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:02:22Z","timestamp":1779195742000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/120505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,19]]},"references-count":66,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,4,19]]},"published-print":{"date-parts":[[2018,4,19]]}},"alternative-id":["10.1172\/jci.insight.120505"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.120505","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,19]]},"article-number":"e120505"}}